top of page

Search Results

Results found for "GPCR Drug Design"

  • Are You Guessing or Forecasting? Master GPCR Pharmacologic Models Before It’s Too Late

    🔹 Elevate your strategy → Building clarity in GPCR drug discovery Even the strongest GPCR programs GPCR University Learner Dr. GPCR Podcast - Surviving Discovery’s Gauntlet Dr. Find your edge:  Dodge the traps that derail real drug discovery careers.   Listen Now – Real Lessons from a GPCR Expert ➤ The future of GPCR isn’t waiting. GPCR Team Read Full Edition ➤

  • A Note from Yamina: Building the Next Chapter of Dr. GPCR

    GPCR. Dear Dr. GPCR, it was with a simple goal: to connect people who shared a passion for GPCR science and discovery GPCR Foundry  — our R&D and biotech hub designed to bridge GPCR science with execution. The Dr. GPCR Retreat  — our largest in-person event yet, designed to bring together scientists, industry leaders GPCR About Dr. GPCR Dr.

  • Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!

    with real-time kinetics Discovering new ligands and GPCR behaviors for unique drug profiles   GPCR Event Logo Contest : Let your creativity shine by submitting your design for the Logo Contest before August relaxation of airway smooth muscle GPCR Binders, Drugs, and more Expanding Structure-Activity Relationships breathe new life into schizophrenia pipeline GPCR Dynamics Reveal Mechanisms for Drug Discovery DMS: in drug discovery October 2024 | Biologics US 2024   October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry

  • Targeting Intracellular Allosteric Sites in GPCRs

    For this reason, GPCRs have been a focus of drug development for decades due to their role in regulating Conventional GPCR drug discovery has largely focused on orthosteric sites, but recent breakthroughs in The process of designing and evaluating biased ligands for GPCRs is complex but essential for understanding for designing effective drug molecules. allosteric agonists and establish a strong foundation for developing biased drugs targeting GPCRs.

  • Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right

    this week:  5-MeO-DMT: the "God Molecule"; Novo Nordisk looks to next generation of obesity, diabetes drugs Upcoming events:  “Drug Discovery at Superluminal Speeds”; and Discovery on Target 2025—GPCR track you replace inference with models that disentangle mechanism—so your next go/no-go, dose range, and assay design ) is set to be a high-signal GPCR forum—bridging biased signaling, allostery, and structure-guided design Attendee Ready to turn ambiguous signals into confident, defensible decisions—and join a community designed

  • The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology

    Watch Episode 170 What We’re Missing in Pain Research In GPCR drug discovery, receptors typically steal explicitly interested in GPCR signaling... but the thing about GPCRs... is you always kind of end up landing at a GPCR as a major target." Serafini highlighted that in modern pain drug development, the field has remained too focused on ion Takeaway Forget what you think you know about GPCR drug targets.

  • From Farm Fields to GPCR Discovery, GLP-1 and GIP

    GPCRs Re-Enter the Story — Not as Theory, but as Tools GPCRs have always been powerful drug targets — yet challenging to drug. That partnership eventually produced fluorescent GPCR tools  that allow researchers to visualize GPCR are expressed Observing which cell types  respond to different therapies Understanding why similar drugs Emerging direction: Peptide–drug conjugates for precision targeting.

  • Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools

    GPCR. dramatically improve how scientists measure ligand-receptor interactions, visualize binding in live cells, and design GPCR empowers scientists and companies advancing receptor biology and drug discovery. a biotech company based in Spain that specializes in the development of optimal chemical tools for drug generation of conjugates, such as labeled ligands, with excellent affinity and pharmacological profiles, designed

  • Illuminating the draggable GPCR-ome

    GPCR Virtual Cafe. This time with none other than Dr. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

  • How a Failed Med School Dream Sparked a GPCR Biotech Revolution

    drug discovery. translational research models, further refining his interest in bridging molecular insights with therapeutic design could be leveraged for therapeutic innovation, he saw a gap in the drug discovery landscape. The company’s goal is to model receptor dynamics — including biased signaling — to predict drug behavior early career redirection to startup setbacks, each step has added new layers to his thinking about drug

  • Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...

    October 2022 Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR ligands "G-protein coupled receptors (GPCRs) have been largely targeted in a wide range of diseases, but few therapies have been directed against GPCRs in the field of cancer, partly because of the lack imaging, and as possible new tools used for target validation in drug screening methodologies." Read more at the source #DrGPCR #GPCR #IndustryNews

  • Community guidelines for GPCR ligand bias: IUPHAR review 32

    August 2022 "GPCRs modulate a plethora of physiological processes and mediate the effects of one-third of FDA-approved drugs. Ligands eliciting biased signalling may constitute better drugs with higher efficacy and fewer adverse Here, we provide guidelines and terminology for any scientists to design and report ligand bias experiments Read more at the source #DrGPCR #GPCR #IndustryNews

  • Single-molecule counting applied to the study of GPCR oligomerization

    signaling proteins that participate in many vital physiological functions making them a popular target for drug Read more at the source #DrGPCR #GPCR #IndustryNews

  • Exploring the Breakthroughs in GPCR Research

    GPCRs remain one of the most prolific and fertile therapeutic drug targets. drug discovery. Logo Contest: Unleash your creativity and submit your design by August 15, 2024. in drug discovery October 2024 | Biologics US 2024 October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry Director GPCR Drug Discovery Biologist Post-Doctoral Scientist- Molecular Pharmacology (FDE) Join Dr.

  • New Tools, Smart Signals, and The Kenakin Brief

    Hello GPCR Trailblazers, This week, we’re spotlighting Celtarys Research, our newest partner, featured Maria Majellaro, highlighting their fluorescent ligand tools for live-cell GPCR assays.   GPCR Updates Terry’s Corner Is Coming – Get Early Access and Updates    Terry’s Corner is launching Explore Terry's Corner From Chemistry Lab to GPCR Partner – New Podcast with Celtarys Dr. GPCR Team

  • GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions

    GPCR targeting drugs: orthosteric vs allosteric sites Most of the drugs targeting GPCRs bind to the orthosteric Despite the existence of numerous drugs designed for this primary binding site, there are significant with accessory proteins, dimerization, phosphorylation, internalization, or desensitization), the same drug This variability in drug effects is due to different ligands inducing unique GPCR conformations that To understand how ligands or drugs affect GPCRs is crucial to grasp the dynamics of these conformational

  • Mark Schmeizl - Dr. GPCR Podcast

    GPCR podcast is now available! Our guest is Mark Schmeizl! Listen where you get your podcasts https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #drgpcr #gpcr #podcast

  • Molecular insights into psychedelic drug action

    factors has renewed interest in the scientific understanding and translational potential of psychedelic drugs incremental progress in basic and clinical research, and the reconsideration and relaxation of existing drug With the United States Food and Drug Administration's designation of psilocybin as a "Breakthrough Therapy Here we review the current knowledge regarding the molecular details of psychedelic drug actions and Read more at the source #DrGPCR #GPCR #IndustryNews

  • GPCR Therapeutics Expands Scientific Advisory Board

    May 2022 "Seoul, South Korea, 28 April 2022 – GPCR therapeutics, Inc., a venture-backed clinical stage international biopharmaceutical company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR) pairs, today announced four appointments to its Scientific Advisory GPCR just had a very successful first meeting including all the Scientific Advisory Board." Read more at the source #DrGPCR #GPCR #IndustryNews

  • Join the #GPCR movement today!

    GPCR Ecosystem paid membership with extra benefits? 🔬Join the #GPCR movement today! ➡️ https://www.ecosystem.drgpcr.com/plans-pricing #gpcr #drgpcr

  • PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design

    October 2022 "While the role of G-protein-coupled receptors (GPCR) in cancer is acknowledged, their underlying Protease-activated receptors (PAR), a subgroup of GPCRs, form a family of four members (PAR1-4) centrally We propose that Pc(4-4) may serve as a powerful drug not only toward PAR-expressing tumors but also for Read more at the source #DrGPCR #GPCR #IndustryNews

  • Dr. Adriano Marchese - Dr. GPCR Podcast

    GPCR podcast is now available! Our guest is Dr. Adriano Marchese! Learn about his remarkable career and research in #GPCR signaling and trafficking. Listen where you get your podcasts https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #drgpcr #gpcr #podcast

  • Quantifying the kinetics of GPCR signaling

    Join us and learn how to quantify your kinetic GPCR signaling from the expert himself: Dr. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

  • Ben Clements on Rescuing Opioids with GPCR Modulators

    His work highlights how foundational GPCR science can drive therapeutic innovation. The GPCR Angle Ben sees GPCRs as untapped goldmines for drug discovery. Ready to dive deeper into GPCR drug discovery? Want to push the boundaries of GPCR drug discovery? Start learning with our GPCR University today. _______________ Keyword Cloud: GPCR research community , GPCR drug discovery, mu-opioid receptor, positive allosteric modulators, GPCR training program, GPCR

  • AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors

    August 2022 "As important drug targets, G protein-coupled receptors (GPCRs) play pivotal roles in a wide Extensive efforts of structural biology have been made on the study of GPCRs. differences impeded the use of predicted structure models in the functional study and structure-based drug design of GPCRs, which required reliable high-resolution structural information." Read more at the source #DrGPCR #GPCR #IndustryNews

  • Diversity and specificity in location-based signaling outputs of neuronal GPCRs

    August 2022 "The common mechanisms by which members of the G protein-coupled receptor (GPCR) family respond However, it is becoming increasingly clear that GPCRs show great diversity in their intracellular location Here we will discuss recent studies on the diversity of location, effectors, and signaling of GPCRs, and how these could interact to generate specific spatiotemporal patterns of GPCR signaling in cells. Read more at the source #DrGPCR #GPCR #IndustryNews

  • Multifunctional role of GPCR signaling in epithelial tube formation

    Rho1 signaling is activated by G-protein-coupled receptor (GPCR) signaling at the cell surface. During Drosophila embryonic salivary gland (SG) invagination, the GPCR ligand Folded gastrulation (Fog Here, we reveal that the Smog GPCR transduces Fog signal to regulate Rho kinase accumulation and myosin Read more at the source #DrGPCR #GPCR #IndustryNews

  • Dr. Mark Connor - Dr. GPCR Podcast

    GPCR podcast is now available! Our guest is Dr. Mark Connor! Learn more about #GPCRs and life as an academic wearing different hats. Listen nowhere you get your podcasts. https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #gpcr #drgpcr

  • High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands

    High-content screening (HCS) has become a cornerstone in GPCR and phenotypic drug discovery, enabling Overcoming them requires careful assay design and strategic use of the right fluorescent probes. In this blog, you’ll learn:  How HCS works and why it is increasingly central to GPCR-based drug discovery Assay Design and Pilot Optimization Successful HCS begins with a clearly defined biological question Conclusion High-content screening continues to reshape GPCR drug discovery, offering richer biological

  • Immerse yourself in the Dr. GPCR Ecosystem!

    GPCR Ecosystem with a paid membership for extra benefits. Catch up with the latest #GPCR news, our monthly Virtual Cafe, and much more! Join the #GPCR movement today! ➡️ https://bit.ly/3SUkB8D

bottom of page